In recent trading session, Aptose Biosciences Inc (NASDAQ:APTO) saw 1.21 million shares changing hands at last check today with its beta currently measuring 0.88. Company’s recent per share price level of $0.22 trading at $0.01 or 2.70% at last check today assigns it a market valuation of $13.18M. That most recent trading price of APTO’s stock is at a discount of -1081.82% from its 52-week high price of $2.60 and is indicating a premium of 40.91% from its 52-week low price of $0.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.73 million shares which gives us an average trading volume of 6.53 million if we extend that period to 3-months.
For Aptose Biosciences Inc (APTO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.35 in the current quarter.
Aptose Biosciences Inc (NASDAQ:APTO) trade information
Upright in the green today for gaining 2.70%, in the last five days APTO remained trading in the red while hitting it’s week-highest on Monday, 01/06/25 when the stock touched $0.22 price level, adding 10.2% to its value on the day. Aptose Biosciences Inc’s shares saw a change of -2.82% in year-to-date performance and have moved -7.03% in past 5-day. Aptose Biosciences Inc (NASDAQ:APTO) showed a performance of 8.12% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.15 days to cover the short interests.
Aptose Biosciences Inc (APTO) estimates and forecasts
Statistics highlight that Aptose Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -69.38% of value to its shares in past 6 months, showing an annual growth rate of 76.39% while that of industry is 16.50. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 10.18% during past 5 years.
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
Insiders are in possession of 6.10% of company’s total shares while institution are holding 5.41 percent of that, with stock having share float percentage of 5.76%. Investors also watch the number of corporate investors in a company very closely, which is 5.41% institutions for Aptose Biosciences Inc that are currently holding shares of the company. DOHENY ASSET MANAGEMENT /CA is the top institutional holder at APTO for having 50550.0 shares of worth $0.32 million. And as of 2024-06-30, it was holding 0.3849 of the company’s outstanding shares.
The second largest institutional holder is CALDWELL SUTTER CAPITAL, INC., which was holding about 92.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.0007 of outstanding shares, having a total worth of $70.0.
